By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...
Most weight loss drugs were meant to be administered as treatment for those with Type 2 Diabetes Mellitus (T2DM), and weight ...
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...
A biopharmaceutical company and its executives misled investors ahead of its 2024 initial public offering about a key ...
Doty recounted the long list of the ways she tried—and failed—to lose weight over the years: Richard Simmons, Weight Watchers ...
( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...
Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...